COPD and Asthma Devices Market by Inhalers Type (Drug powder, Metered Dose, Soft Mist), Nebulizers (Compressor, Ultrasonic, Mesh) - Global Opportunity Analysis and Industry Forecasts, 2015 - 2022

CHAPTER 1 INTRODUCTION

1.1 Report description

1.2 Key benefits

1.3 Key market segments

1.4 Research methodology

1.4.1 Primary research

1.4.2 Secondary Research

1.4.3 Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

2.1 CXO perspective

2.2 Market beyond what to expect by 2027

2.2.1 Moderate growth scenario

2.2.2 Rapid growth scenario

2.2.3 Diminishing growth scenario

CHAPTER 3 MARKET OVERVIEW

3.1 Market definition and scope

3.2 Key findings

3.2.1 Top impacting factors

3.2.2 Top investment pockets

3.2.3 Top winning strategies

3.3 Porters five forces analysis

3.3.1 Bargaining power of buyers (High)

3.3.2 Bargaining power of suppliers (Low to Moderate)

3.3.3 Threat of new entrants (Low)

3.3.4 Threat of substitutes (High)

3.3.5 Intense competitive rivalry

3.4 Value chain analysis

3.5 Market share analysis, 2015

3.6 Government regulations

3.6.1 COPD devices regulations in Europe and in the U.S.

3.6.2 COPD devices regulations in Asia-Pacific

3.7 Drivers

3.7.1 Daily exposure to environmental pollution

3.7.2 Increase in population susceptible to indoor air pollutants

3.7.3 Portability of the drug delivery devices

3.7.4 Increasing population of Active smokers

3.7.5 Rising government initiatives

3.8 Restraints

3.8.1 Increasing price competition and deterioration of material quality

3.8.2 Overall high cost of asthma treatment is a challenge for the patients

3.8.3 Incompetent reimbursement support

3.9 Opportunities

3.9.1 Patent expiration for blockbuster drugs

3.9.2 Soft Mist Inhalers (SMIs): future growth driver

CHAPTER 4 WORLD COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE

4.1 Inhalers

4.1.1 Drug powdered inhalers (DPIs)

4.1.1.1 Key market trends

4.1.1.2 Key growth factors

4.1.1.3 Market size and forecast

4.1.2 Metered dose inhalers (MDIs)

4.1.2.1 Key market trends

4.1.2.2 Key growth factors

4.1.2.3 Market size and forecast

4.1.3 Soft mist inhalers

4.1.3.1 Key market trends

4.1.3.2 Key growth factors

4.1.3.3 Market size and forecast

4.2 Nebulizers

4.2.1 Compressor nebulizers

4.2.2 Ultrasonic nebulizers

4.2.3 Mesh nebulizers

CHAPTER 5 WORLD COPD & ASTHMA DEVICE MARKET, BY GEOGRAPHY

5.1 Introduction

5.2 Market size and forecast

5.3 North America

5.3.1 Key market trends

5.3.2 Market size and forecast

5.3.3 U.S

5.3.3.1 Market size and forecast

5.3.4 Canada

5.3.4.1 Market size and forecast

5.3.5 Mexico

5.3.5.1 Market size and forecast

5.4 Europe

5.4.1 Key market trends

5.4.2 Market size and forecast

5.4.3 UK

5.4.3.1 Market size and forecast

5.4.4 France

5.4.4.1 Market size and forecast

5.4.5 Germany

5.4.5.1 Market size and forecast

5.4.6 Italy

5.4.6.1 Market size and forecast

5.4.7 Russia

5.4.7.1 Market size and forecast

5.4.8 Others European countries

5.4.8.1 Market size and forecast

5.5 Asia-Pacific

5.5.1 Key market trends

5.5.2 Key growth factors and opportunities

5.5.3 Market size and forecast

5.5.4 India

5.5.4.1 Market size and forecast

5.5.5 China

5.5.5.1 Market size and forecast

5.5.6 Japan

5.5.6.1 Market size and forecast

5.5.7 Australia

5.5.7.1 Market size and forecast

5.5.1 Others

5.5.1.1 Market size and forecast

5.6 LAMEA

5.6.1 Key market trends

5.6.2 Market size and forecast

5.6.3 Brazil

5.6.3.1 Market size and forecast

5.6.4 Argentina

5.6.4.1 Market size and forecast

5.6.5 Colombia

5.6.5.1 Market size and forecast

5.6.6 Saudi Arabia

5.6.6.1 Market size and forecast

5.6.7 Turkey

5.6.7.1 Market size and forecast

5.6.8 Others

5.6.8.1 Market size and forecast

CHAPTER 6 COMPANY PROFILES

6.1 Glaxosmithcline PLC

6.1.1 Company overview

6.1.2 Operating business segment overview

6.1.3 Business performance

6.1.4 Key strategies move and development

6.1.5 SWOT analysis

6.2 Novartis AG

6.2.1 Company overview

6.2.2 Operating business segment overview

6.2.3 Business performance

6.2.4 Key strategies and development

6.2.5 SWOT analysis

6.3 Merck & Company

6.3.1 Operating business segment overview

6.3.2 Business performance

6.3.3 SWOT analysis

6.4 Philips Healthcare (Division of Royal Philips Company)

6.4.1 Company overview

6.4.2 Business performance

6.4.3 Strategic moves and developments

6.4.4 SWOT analysis

6.5 AstraZeneca Plc.

6.5.1 Company overview

6.5.2 Operating business segment overview

6.5.3 Business performance

6.5.4 Strategic moves and developments

6.5.5 SWOT analysis

6.6 3M Healthcare

6.6.1 Company overview

6.6.2 Business performance

6.6.3 Strategy move and development

6.6.4 SWOT analysis

6.7 GF Health Products

6.7.1 Company overview

6.7.2 Strategic moves and developments

6.7.3 SWOT analysis

6.8 Sunovion Pharmaceuticals Inc.

6.8.1 Company overview

6.8.2 Operating business segment overview

6.8.3 Business performance

6.8.4 Strategic moves and developments

6.8.5 SWOT analysis

6.9 Smith Medicals, Inc.

6.9.1 Company overview

6.9.2 Business performance

6.9.3 SWOT analysis

6.10 Baxter International

6.10.1 Company overview

6.10.2 Operating business segment overview

6.10.3 Business performance

6.10.4 SWOT analysis

6.11 Boehringer Ingelheim GmbH

6.11.1 Company overview

6.11.2 Operating business segment overview

6.11.3 Business performance

6.11.4 Key strategies and developments

6.11.5 SWOT analysis

List of Figures

FIG. 1 IMPACT ANALYSIS OF MODERATE GROWTH SCENARIO, 2022-2027

FIG. 2 IMPACT ANALYSIS OF RAPID GROWTH SCENARIO, 20222027

FIG. 3 IMPACT ANALYSIS OF DIMINISHING GROWTH SCENARIO, 20222027

FIG. 4 TOP FACTORS IMPACTING WORLD COPD AND ASTHMA DEVICES MARKET, 20152022

FIG. 5 TOP INVESTMENT POCKETS OF WORLD COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPES

FIG. 6 TOP WINNING STRATEGY IN COPD AND ASTHMA DEVICES MARKET, 20122016

FIG. 7 TOP WINNING STRATEGIES, BY APPLICATION, 20122016

FIG. 8 PORTERS FIVE FORCES ANALYSIS OF WORLD COPD AND ASTHMA DEVICES MARKET

FIG. 9 VALUE CHAIN ANALYSIS OF WORLD COPD AND ASTHMA DEVICES

FIG. 10 MARKET SHARE ANALYSIS OF COPD AND ASTHMA DEVICES MARKET, 2015 (%)

FIG. 11 COPD AND ASTHMA INCIDENCE IN GREAT BRITAIN, 2003-2013

FIG. 12 U.S. ASTHMA AND COPD DEVICES MARKET, 20152022 ($MILLION)

FIG. 13 CANADA COPD AND ASTHMA DEVICES MARKET, 20152022 ($MILLION)

FIG. 14 MEXICO COPD AND ASTHMA DEVICES MARKET, 20152022 ($MILLION)

FIG. 15 UK COPD AND ASTHMA DEVICES MARKET, 2015-2022 ($MILLION)

FIG. 16 FRANCE COPD AND ASTHMA DEVICES MARKET, 2015-2022 ($MILLION)

FIG. 17 GERMANY COPD AND ASTHMA DEVICES MARKET, 2015-2022 ($MILLION)

FIG. 18 ITALY COPD AND ASTHMA DEVICES MARKET, 2015-2022 ($MILLION)

FIG. 19 RUSSIA COPD AND ASTHMA DEVICES MARKET, 2015-2022 ($MILLION)

FIG. 20 REST OF EUROPEAN COPD AND ASTHMA DEVICES MARKET, 2015-2022 ($MILLION)

FIG. 21 INDIA COPD AND ASTHMA DEVICES MARKET, 2015-2022 ($MILLION)

FIG. 22 CHINA COPD AND ASTHMA DEVICES MARKET, 2015-2022 ($MILLION)

FIG. 23 JAPAN COPD AND ASTHMA DEVICES MARKET, 2015-2022 ($MILLION)

FIG. 24 AUSTRALIA COPD AND ASTHMA DEVICES MARKET, 2015-2022 ($MILLION)

FIG. 25 REST OF APAC COPD AND ASTHMA DEVICES MARKET, 2015-2022 ($MILLION)

FIG. 26 BRAZIL COPD AND ASTHMA MARKET, 20152022 ($MILLION)

FIG. 27 ARGENTINA COPD AND ASTHMA MARKET, 20152022 ($MILLION)

FIG. 28 COLOMBIA COPD AND ASTHMA MARKET, 20152022 ($MILLION)

FIG. 29 SAUDI ARABIA COPD AND ASTHMA MARKET, 20152022 ($MILLION)

FIG. 30 TURKEY COPD AND ASTHMA MARKET, 20152022 ($MILLION)

FIG. 31 OTHERS COPD AND ASTHMA MARKET, 20152022 ($MILLION)

FIG. 32 GLAXOSMITHKLINE PLC, REVENUE 2013-2015 ($MILLION)

FIG. 33 GLAXOSMITHKLINE PLC, REVENUE BY GEOGRAPHY 2015 (%)

FIG. 34 GLAXOSMITHKLINE PLC REVENUE BY BUSINESS SEGMENTS, 2015 (%)

FIG. 35 SWOT ANALYSIS OF GLAXOSMITHKLINE PLC

FIG. 36 NOVARTIS AG REVENUE 2013-2015 ($MILLION)

FIG. 37 NOVARTIS AG REVENUE BY GEOGRAPHY, 2015 (%)

FIG. 38 NOVARTIS AG REVENUE BY BUSINESS SEGMENTS, 2015 (%)

FIG. 39 SWOT ANALYSIS OF NOVARTIS AG

FIG. 40 MERCK & CO. REVENUE, 2013-2015 ($MILLION)

FIG. 41 MERCK REVENUE BY GEOGRAPHY, 2015 (%)

FIG. 42 MERCK REVENUE BY BUSINESS UNITS, 2015 (%)

FIG. 43 SWOT ANALYSIS OF MERCK

FIG. 44 PHILIPS REVENUE, 2013-2015, ($MILLION)

FIG. 45 PHILIPS REVENUE, BY BUSINESS UNITS, 2015 (%)

FIG. 46 SWOT ANALYSIS OF PHILIPS HEALTHCARE

FIG. 47 ASTRAZENECA INC REVENUE, 2013-2015 ($MILLION)

FIG. 48 ASTRAZENECA REVENUE, BY SEGMENT 2015 (%)

FIG. 49 ASTRAZENECA REVENUYE BY GEOGRAPHY, 2013 (%)

FIG. 50 ASTRAZENECA INC. SWOT ANALYSIS

FIG. 51 3M REVENUE, 2013-2015 ($MILLION)

FIG. 52 3M REVENUE BY BUSINESS SEGMENTS, 2015 (%)

FIG. 53 3M REVENUE BY GEOGRAPHY, 2015 (%)

FIG. 54 SWOT ANALYSIS OF 3M

FIG. 55 SWOT ANALYSIS OF GF HEALTH PRODUCTS

FIG. 56 SUNOVION REVENUE, 2012-2015 ($MILLION)

FIG. 57 SUNOVION REVENUE BY GEOGRAPHY, 2015 (%)

FIG. 58 SWOT ANALYSIS OF SUNOVION INC.

FIG. 59 SMITH MEDICAL INC. REVENUE, 2013-2015 ($MILLION)

FIG. 60 SMITH MEDICAL INC. REVENUE BY GEOGRAPHY, 2015 (%)

FIG. 61 SMITH MEDICAL INC- SWOT ANALYSIS

FIG. 62 BAXTER INTERNATIONAL REVENUE, 2013-2015 ($MILLION)

FIG. 63 BAXTER INTERNATIONAL REVENUE BY GEOGRAPHY, 2015 (%)

FIG. 64 BAXTER INTERNATIONAL REVENUE BY BUSINESS SEGMENTS, 2015 (%)

FIG. 65 SWOT ANALYSIS OF BAXTER INTERNATIONAL

FIG. 66 BOEHRINGER INGELHEIM REVENUE, 2013-2015 ($MILLION)

FIG. 67 BOEHRINGER INGELHEIM REVENUE BY GEOGRAPHY, 2015 (%)

FIG. 68 BOEHRINGER INGELHEIM REVENUE BY BUSINESS SEGMENTS, 2015 (%)

FIG. 69 SWOT ANALYSIS OF BOEHRINGER INGELHEIM GMBH

List of Tables

TABLE 1 WORLD COPD AND ASTHMA DEVICES MARKET, MODERATE GROWTH SCENARIO BY GEOGRAPHY, 20222027 ($MILLION)

TABLE 2 WORLD COPD AND ASTHMA DEVICES MARKET, RAPID GROWTH SCENARIO BY GEOGRAPHY, 20222027 ($MILLION)

TABLE 3 WORLD COPD AND ASTHMA DEVICES MARKET, DIMINISHING GROWTH SCENARIO BY GEOGRAPHY, 20222027 ($MILLION)

TABLE 4 ADVANTAGES AND DISADVANTAGES OF MARKETED PORTABLE INHALER DEVICES

TABLE 5 PERCENTAGE OF SMOKER POPULATION BY ETHNICITY, 2012

TABLE 6 TOP 10 COUNTRIES HEALTHCARE EXPENDITURE, 2013

TABLE 7 WORLD COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE, 20152022, ($MILLION)

TABLE 8 RESCUE INHALERS VS MAINTENANCE INHALERS

TABLE 9 COMMON TYPES OF INHALERS

TABLE 10 TOP 10 COPD INHALERS

TABLE 11 WORLD COPD AND ASTHMA INHALERS MARKET, BY TYPE, 2015-2022, ($MILLION)

TABLE 12 WORLD COPD AND ASTHMA INHALERS MARKET, BY GEOGRAPHY, 2015-2022, ($MILLION)

TABLE 13 DRY POWDER INHALERS

TABLE 14 WORLD DRY POWDER INHALERS (DPI) MARKET, BY GEOGRAPHY, 20152022, $MILLION

TABLE 15 TYPES OF METERED DOSE INHALERS (MDIS)

TABLE 16 WORLD METERED DOSE INHALERS (MDI) MARKET, BY GEOGRAPHY, 20152022, $MILLION

TABLE 17 WORLD SOFT MIST INHALERS (SMI) MARKET, BY GEOGRAPHY,

TABLE 18 2015-2022, $MILLION

TABLE 19 COMMERCIALIZED NEBULIZERS AND ITS COST

TABLE 20 WORLD NEBULIZERS MARKET, BY TYPE, 20152022, ($MILLION)

TABLE 21 WORLD NEBULIZERS MARKET, BY GEOGRAPHY, 2015-2022, ($MILLION)

TABLE 22 WORLD COMPRESSOR NEBULIZERS MARKET, BY GEOGRAPHY, 2015-2022, ($MILLION)

TABLE 23 WORLD ULTRASONIC NEBULIZERS MARKET, BY GEOGRAPHY, 20152022, ($MILLION)

TABLE 24 WORLD MESH NEBULIZERS MARKET, BY GEOGRAPHY, 20152022, ($MILLION)

TABLE 25 WORLD COPD AND ASTHMA DEVICES MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)

TABLE 26 NORTH AMERICA COPD AND ASTHMA DEVICES MARKET, BY TYPE, 2015-2022 ($MILLION)

TABLE 27 EUROPE COPD AND ASTHMA DEVICES MARKET, BY TYPE; 20152022 ($MILLION)

TABLE 28 ASIA-PACIFIC COPD DEVICES MARKET, BY TYPE, 2015-2022 ($MILLION)

TABLE 29 LAMEA COPD AND ASTHMA MARKET, BY TYPE, 2015-2022 ($MILLION)

TABLE 30 GLAXOSMITHKLINE PLC SNAPSHOT

TABLE 31 GLAXOSMITHKLINE PLC OPERATING SEGEMENTS

TABLE 32 NOVARTIS AG SNAPSHOT

TABLE 33 NOVARTIS AG OPERATING SEGEMENTS

TABLE 34 MERCK COMPANY SNAPSHOT

TABLE 35 MERCK OPERATING SEGEMENTS

TABLE 36 PHILIPS HEALTHCARE BUSINESS SNAPSHOT

TABLE 37 ASTRAZENECA INC. SNAPSHOT

TABLE 38 ASTRAZENACA INC. OPERATING SEGMENT OVERVIEW

TABLE 39 3M SNAPSHOT

TABLE 40 GF HEALTH PRODUCTS SNAPSHOT

TABLE 41 SUNOVION SNAPSHOT

TABLE 42 SUNOVION OPERATING SEGEMENTS

TABLE 43 SMITH MEDICAL INC SNAPSHOT

TABLE 44 BAXTER SNAPSHOT

TABLE 45 BOEHRINGER INGELHEIM GMBH SNAPSHOT

TABLE 46 BOEHRINGER INGELHEIM GMBH OPERATING SEGEMENTS